METHODOLOGICAL APPROACHES TO EXPERT EVALUATION OF PRECLINICAL AND CLINICAL TRIALS OF HUMAN IMMUNOGLOBULIN PRODUCTS

• Published in: Medit͡s︡inskai͡a︡ immunologii͡a Vol. 19; no. 5; p. 615
• Main Authors: Ivanov, V B, Mosyagin, V D, E Yu Kudasheva, Olefir, Yu V, Merkulov, V A, Borisevitch, I V, Bondarev, V P
• Format: Journal Article
• Language: Russian
• Published: Saint Petersburg Russian Association of Allerologists and Clinical Immuniologists, St. Petersburg Branch 01.01.2017
• Subjects: Clinical trials; Conduction; Immunoglobulins; Infectious diseases; Legislation
• ISSN: 1563-0625; 2313-741X
• DOI: 10.15789/1563-0625-2017-5-615-628

The article considers the experience of Russian and leading foreign regulatory agencies in organisation and conduction of preclinical and clinical trials of human immunoglobulin products. The authors suggest a classification of human immunoglobulins and provide updated information on authorization of these products in Russia. The article summarizes methodological approaches, basic scientific principles and criteria relating to expert evaluation of preclinical and clinical trials of blood products. The authors further define the expert body’s requirements for data on preclinical and clinical trials of human normal immuniglobulins and human specific immunoglobulins for the prevention and/or treatment of infectious and non-infectious diseases which are submitted as part of applications for marketing authorization or marketing authorization variation. The article suggests programs of preclinical and clinical trials for human normal immunoglobulins and human specific immunoglobulins for the prevention and/or treatment of infectious and non-infectious diseases that are aligned with the Russian legislation and Eurasian Economic Union’s regulations on medicines circulation, and have been elaborated with respect to the guidelines of the European Medicines Agency.